ArticleThe EMBO journal2026
Uncovering essential RNA components of fusion oncoprotein condensates using bicon-seq.
Article in The EMBO journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Fusion oncoproteins drive aggressive leukemias by mediating aberrant gene expression within specialized biomolecular condensates that contain various biomolecules. While RNA is known to influence condensate properties, the RNA constituents of fusion protein-containing onco-condensates remain poorly defined. Here, we use bicon-seq (biotinylated-isoxazole-mediated precipitation of condensome and RNA sequencing) to globally profile condensate-associated RNAs from cellular samples. Using experimental perturbation of cytoplasmic RNA-containing condensates, we demonstrated that bicon-seq accurately quantifies changes in RNA solubility, that correlate with published RNA enrichment in these structures. In leukemia cells driven by the NUP98::KDM5A fusion oncoprotein, bicon-seq revealed highly conserved long non-coding RNAs (lncRNAs) that are associated with NUP98::KDM5A onco-condensates. Among them, the lncRNA Gas5 was highly expressed and essential for the proliferation of AML cells. Mechanistically, Gas5 co-localized with NUP98::KDM5A in condensates and modulated NUP98::KDM5A chromatin binding and the expression dynamics of differentiation/apoptosis-associated genes in AML cells. Together, our results introduce a novel approach to systematically profile condensate-associated RNAs and identify the lncRNA Gas5 as a critical regulator of NUP98::KDM5A-driven transcription in AML cells.
Identifiers
42875649What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.